loadpatents
name:-0.017637014389038
name:-0.0098378658294678
name:-0.001101016998291
Kirkovsky; Leonid I. Patent Filings

Kirkovsky; Leonid I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kirkovsky; Leonid I..The latest application filed is for "radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy".

Company Profile
0.7.8
  • Kirkovsky; Leonid I. - Chesterfield MO
  • Kirkovsky; Leonid I. - Lexington MA
  • Kirkovsky; Leonid I. - San Diago CA
  • Kirkovsky, Leonid I. - San Diego CA
  • Kirkovsky; Leonid I. - Memphis TN
  • Kirkovsky, Leonid I - Memphis TN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
App 20080193380 - Dalton; James T. ;   et al.
2008-08-14
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
Grant 7,344,700 - Dalton , et al. March 18, 2
2008-03-18
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
Grant 7,129,377 - Miller , et al. October 31, 2
2006-10-31
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
Grant 7,041,844 - Miller , et al. May 9, 2
2006-05-09
Irreversible selective androgen receptor modulators and methods of use thereof
App 20060035966 - Dalton; James T. ;   et al.
2006-02-16
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
App 20040248862 - Miller, Duane D. ;   et al.
2004-12-09
Irreversible selective androgen receptor modulators and methods of use thereof
App 20040087810 - Dalton, James T. ;   et al.
2004-05-06
Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy
App 20040052727 - Dalton, James T. ;   et al.
2004-03-18
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
App 20030232882 - Miller, Duane D. ;   et al.
2003-12-18
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
Grant 6,482,861 - Miller , et al. November 19, 2
2002-11-19
Non-steroidal Radiolabeled Agonist/antagonist Compounds And Their Use In Prostate Cancer Imaging
App 20020098148 - MILLER, DUANE D. ;   et al.
2002-07-25
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
App 20010012839 - Miller, Duane D ;   et al.
2001-08-09
Non-steroidal agonist compounds and their use in male hormone therapy
Grant 6,160,011 - Miller , et al. December 12, 2
2000-12-12
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
Grant 6,071,957 - Miller , et al. June 6, 2
2000-06-06
Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
Grant 6,019,957 - Miller , et al. February 1, 2
2000-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed